• OPEN AN ACCOUNT
Indian Indices
Sensex
79,310.01 2,008.61
( 2.60%)
Global Indices
Nasdaq
51,872.69 -1,504.43
(-2.82%)
Dow Jones
7,442.16 -267.46
(-3.47%)
Hang Seng
60,935.13 -1,253.50
(-2.02%)
Nikkei 225
10,776.27 -52.94
(-0.49%)
Forex
USD-INR
94.73 -0.07
(-0.07%)
EUR-INR
105.99 -0.12
(-0.11%)
GBP-INR
127.06 -0.04
(-0.03%)
JPY-INR
0.60 0.00
(-0.31%)

EQUITY - MARKET SCREENER

AAVAS Financiers Ltd
Industry :  Finance - Housing
BSE Code
ISIN Demat
Book Value()
541988
INE216P01012
680.8007115
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AAVAS
12.75
8983.43
EPS(TTM)
Face Value()
Div & Yield %
88.84
10
0
 

Tatva Chintan Pharma Chem consolidated net profit rises 140.30% in the June 2026 quarter
Jul 17,2026
Net profit of Tatva Chintan Pharma Chem rose 140.30% to Rs 15.98 crore in the quarter ended June 2026 as against Rs 6.65 crore during the previous quarter ended June 2025. Sales rose 42.96% to Rs 167.06 crore in the quarter ended June 2026 as against Rs 116.86 crore during the previous quarter ended June 2025.

ParticularsQuarter Ended
Jun. 2026Jun. 2025% Var.
Sales167.06116.86 43
OPM %19.3314.83 -
PBDT33.0018.07 83
PBT22.439.10 146
NP15.986.65 140